TinyGemsBreaks Archive - Page 38 of 128

TuesdayFeb 06, 2024 2:35 pm

TinyGemsBreaks – Mullen Automotive Inc. (NASDAQ: MULN) Announces Bollinger’s Receipt of IRS Approval for $40K Commercial EV Tax Credit

Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer, today announced that Bollinger Motors (“Bollinger”) has received IRS approval as a “qualified manufacturer” for clean vehicle credits under the Inflation Reduction Act of 2022 (the “IRA”). According to the announcement, the designation enables the Bollinger B4 chassis cab to qualify for the IRA’s new credit for qualified commercial clean vehicles, providing eligible purchasers a tax credit of up to $40,000 per vehicle. “Bollinger Motors is poised for growth and we’re ready to help electrify America’s fleets,” said Robert Bollinger, founder and CEO of Bollinger Motors. “These tax credits are…

TuesdayFeb 06, 2024 12:23 pm

TinyGemsBreaks – Genprex Inc. (NASDAQ: GNPX) Announces Participation at This Month’s BIO CEO & Investor Conference

Genprex (NASDAQ: GNPX), a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes, will be represented at the upcoming BIO CEO & Investor Conference. The conference is scheduled for Feb. 26–27, 2024, in New York City. According to the company, CFO Ryan Confer will present at the two-day event. His presentation, which will begin at 1:30 p.m. ET on Feb. 26, will include an overview of the company's gene therapies for cancer and diabetes; Confer will also be available for in-person, one-on-one meetings with investors through the conference platform. To view the full press release,…

TuesdayFeb 06, 2024 12:09 pm

TinyGemsBreaks – Clene Inc. (NASDAQ: CLNN) CEO Discusses MS Trial Results During Latest Proactive Interview

Clene (NASDAQ: CLNN) CEO Rob Etherington was the featured guest on a recent Proactive interview. According to an announcement, Etherington joined Proactive host Steve Darling to discuss recent news the company has released regarding results from its long-term, open-label extension (“LTE”) of the VISIONARY-MS trial. Clene is a late clinical-stage biopharmaceutical company focused on improving mitochondrial health and protecting neuronal function to treat neurodegenerative diseases, including amyotrophic lateral sclerosis (“ALS”), Parkinson’s disease and multiple sclerosis (“MS”). Etherington and Darling discussed the trial, which involved gathering almost three years of research and information from participants with stable relapsing MS. Darling explained…

MondayFeb 05, 2024 1:00 pm

TinyGemsBreaks — Mullen Automotive Inc. (NASDAQ: MULN) Reports on Production and Deliveries, Moves Forward with Production Line Installation

Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer, is reporting “great strides” with the production and deliveries of its Class 1 and Class 3 commercial EVs. In addition, the company is reporting that its subsidiary, Mullen Advanced Energy LLC, "), is moving forward with the installation of its battery-pack production line at its new 122,000-square-foot, high-energy facility in Fullerton, California. The company announced the new facility in November 2023; the new facility is dedicated to producing next-generation, American-made EV battery components, modules and packs. “We are steadfastly focused on production, production, production,” said Mullen Automotive CEO and chair…

MondayFeb 05, 2024 12:42 pm

TinyGemsBreaks – Genprex Inc. (NASDAQ: GNPX) Phase2a Expansion of Acclaim-1 Clinical Study Enrolls, Doses First Patient

Genprex (NASDAQ: GNPX), a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes, has enrolled and dosed the first patient in the phase 2a expansion portion of its Acclaim-1 clinical study of Reqorsa(R) therapy (quaratusugene ozeplasmid). The study combines Genprex’s proprietary lead product candidate with AstraZeneca's Tagrisso(R) to treat patients with late-stage non-small cell lung cancer (“NSCLC”). An open-label, multicenter phase 1/2 clinical trial, the Accliam-1 trial has completed its phase 1 component and is moving on to phase 2. The company anticipates enrolling an estimated 66 patients in phase 2a, with one-half of the study participants…

MondayFeb 05, 2024 12:16 pm

TinyGemsBreaks – NextPlat Corp. (NASDAQ: NXPL) Announces Upcoming Launch and Expansion of OPKO Health-Branded Storefront

NextPlat (NASDAQ: NXPL, NXPLW), a global e-Commerce provider, is preparing for the launch of its exclusive OPKO Health-branded storefront on Alibaba Group Holding Limited's ("Alibaba")(NYSE: BABA) Tmall Global in China. The move follows the company’s receipt of the initial set of approvals required to operate the store in the country. “We are pleased to reach this strategic milestone with our partners OPKO and Alibaba because we believe in the global potential of health and wellness as millions of consumers in China and around the globe continue to prioritize their wellbeing, contributing to the continued growth of this large and valuable…

FridayFeb 02, 2024 11:53 am

TinyGemsBreaks – Diamond Lake Minerals Inc. (DLMI) Well-Positioned in the Digital Asset and Security Token Space

Diamond Lake Minerals (OTC: DLMI), a company emerging as a leader in the digital asset and security token space, aims to responsibly innovate and combine traditional businesses with the evolving landscape of digital assets. “The company’s primary focus is on the development and support of SEC-registered security tokens, operating across various industries. This industry agnostic approach has allowed Diamond Lake Minerals to achieve significant milestones in technology development, partnerships and regulatory compliance. Incorporating cutting-edge techniques and technologies, Diamond Lake Minerals ensures efficient and secure digital asset management. The leadership team … brings decades of expertise in both traditional and digital…

ThursdayFeb 01, 2024 1:35 pm

TinyGemsBreaks – Diamond Lake Minerals Inc. (DLMI) Paving the Way for a Secure and Transparent Digital Future

Diamond Lake Minerals (OTC: DLMI) CEO Brian J. Esposito, a distinguished business leader, was featured in a recent TechBullion article that delved into his extensive entrepreneurial journey, his early ventures and pivotal role in catapulting DLMI to the forefront of the digital asset and security token space. “One of Esposito’s notable achievements is his takeover of Diamond Lake Minerals Inc. in August 2023. Serving as the CEO, Esposito orchestrated a very remarkable transformation, elevating the company’s market capitalization at present from $1 million to an impressive $156 million. The stock price soared from $0.35 to $5.25 in just over four…

ThursdayFeb 01, 2024 1:18 pm

TinyGemsBreaks – Mullen Automotive Inc. (NASDAQ: MULN) Poised with First-Mover Advantage in Class 1 and Class 3 Commercial Vehicles

Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer, today announced that it continues to capitalize on its first-mover advantage in the U.S. market with production and deliveries of its Class 1 EV cargo vans and Class 3 EV trucks. Mullen began Class 3 vehicle production in August 2023 and Class 1 production in November 2023, with first vehicle deliveries in September 2023 and December 2023, respectively. “While many of the OEMs and new EV companies have launched their EVs with significant losses, Mullen is out-of-the-gate with a positive gross profit margin per vehicle,” said David Michery, CEO and…

WednesdayJan 31, 2024 3:16 pm

TinyGemsBreaks – Diamond Lake Minerals Inc. (DLMI) Featured in Benzinga Partner Interview

Diamond Lake Minerals (OTC: DLMI), which specializes in the development and support of digital assets and SEC-registered security tokens, was recently featured in a Benzinga Partner Studio interview. Brian J. Esposito, CEO of DLMI, joined the program to share his prediction for digital assets and tokenization in 2024. The interview starts off with Esposito speaking of the green light from the SEC for a BTC ETF and how this affects Diamond Lake and its exposure to regulated digital assets. “I think it does a lot of things… I’m excited that they got that pushed across the finish line for multiple…

Spotlighting undiscovered companies with enormous upside potential.

Contact us: (512) 354-7000

TinyGemsBreaks